Imre Pávó
About
Imre Pávó is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Orthopedics and Sports Medicine.
According to data from OpenAlex, Imre Pávó has authored 121 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 29 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Orthopedics and Sports Medicine. Recurrent topics in Imre Pávó's work include Bone health and osteoporosis research (24 papers), Neuroendocrine regulation and behavior (18 papers) and Diabetes Treatment and Management (16 papers). Imre Pávó is often cited by papers focused on Bone health and osteoporosis research (24 papers), Neuroendocrine regulation and behavior (18 papers) and Diabetes Treatment and Management (16 papers). Imre Pávó collaborates with scholars based in Hungary, United States and Austria. Imre Pávó's co-authors include Gerald Crans, Bruce Ettinger, Naveed Sattar, Russell J. Wiese, Astrid Fahrleitner‐Pammer, Harald Dobnig, J Štěpán, Govinda J. Weerakkody, Darren K. McGuire and Adrien Sipos and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.
In The Last Decade
Imre Pávó
118 papers receiving 3.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Imre Pávó Hungary | 33 | 1.5k | 1.2k | 1.0k | 1.0k | 684 | 121 | 3.6k | ||
| Kristine D. Harper United States | 23 | 913 0.6× | 1.6k 1.3× | 671 0.7× | 1.0k 1.0× | 683 1.0× | 37 | 3.1k | ||
| Benjamin Z. Leder United States | 36 | 2.1k 1.5× | 2.8k 2.2× | 1.3k 1.2× | 2.7k 2.7× | 538 0.8× | 89 | 5.5k | ||
| R. Bouillon Belgium | 30 | 840 0.6× | 621 0.5× | 762 0.7× | 432 0.4× | 336 0.5× | 70 | 4.2k | ||
| Hunter Heath United States | 38 | 1.7k 1.2× | 1.4k 1.2× | 1.1k 1.1× | 1.7k 1.7× | 741 1.1× | 129 | 5.9k | ||
| Aase Handberg Denmark | 35 | 1.9k 1.3× | 337 0.3× | 780 0.8× | 267 0.3× | 587 0.9× | 138 | 3.9k | ||
| Mei Li China | 30 | 951 0.7× | 549 0.4× | 136 0.1× | 854 0.8× | 428 0.6× | 215 | 3.2k | ||
| Dorthe Skovgaard Denmark | 28 | 646 0.4× | 1.1k 0.9× | 881 0.9× | 164 0.2× | 898 1.3× | 55 | 3.3k | ||
| D. Thiébaud Switzerland | 32 | 633 0.4× | 1.1k 0.9× | 334 0.3× | 1.4k 1.3× | 360 0.5× | 73 | 3.2k | ||
| Richard Keen United Kingdom | 31 | 673 0.5× | 1.1k 0.9× | 192 0.2× | 419 0.4× | 370 0.5× | 92 | 2.8k | ||
| Robert W. Downs United States | 33 | 2.3k 1.6× | 3.5k 2.8× | 444 0.4× | 2.9k 2.8× | 1.2k 1.8× | 69 | 6.6k |
Countries citing papers authored by Imre Pávó
Since
Specialization
Citations
This map shows the geographic impact of Imre Pávó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imre Pávó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imre Pávó more than expected).
Fields of papers citing papers by Imre Pávó
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Imre Pávó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imre Pávó. The network helps show where Imre Pávó may publish in the future.
Co-authorship network of co-authors of Imre Pávó
This figure shows the co-authorship network connecting the top 25 collaborators of Imre Pávó. A scholar is included among the top collaborators of Imre Pávó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imre Pávó. Imre Pávó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tuttle, Katherine R., Imre Pávó, Axel Haupt, et al.. (2025). Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials. Diabetes Care. 48(3). 430–436.
2.
Heerspink, Hiddo J.L., Katherine R. Tuttle, Imre Pávó, et al.. (2024). Tirzepatide Reduces Albuminuria in Patients with T2D: Post-hoc Pooled Analysis of SURPASS 1-5. Diabetologie und Stoffwechsel. 19(S 01). S75–S75.
3.
Peters, Anne L., Raffaella Buzzetti, Clare J. Lee, et al.. (2024). Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS. The Journal of Clinical Endocrinology & Metabolism. 110(4). e962–e969.
4.
Pávó, Imre, et al.. (2023). Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center. Pediatric Drugs. 25(4). 467–481.
5.
Heerspink, Hiddo J.L., Naveed Sattar, Imre Pávó, et al.. (2023). Effects of tirzepatide versus insulin glargine 100U/ml on kidney outcomes in people with type 2 diabetes in SURPASS-4. Diabetologie und Stoffwechsel. 18(S 01). S61–S61.
6.
Nicholls, Stephen J., Deepak L. Bhatt, John B. Buse, et al.. (2023). Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics. American Heart Journal. 267. 1–11.
7.
Heerspink, Hiddo J.L., Naveed Sattar, Imre Pávó, et al.. (2023). Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis. Diabetes Care. 46(8). 1501–1506.
8.
Prato, Stefano Del, Steven E. Kahn, Imre Pávó, et al.. (2022). Efficacy and Safety of Tirzepatide versus Insulin Glargine in Patients with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4). Diabetologie und Stoffwechsel. 17(S 01). S20–S21.
9.
Szabó, Renáta, Krisztina Kupai, Médea Veszelka, et al.. (2021). Hormone Replacement Therapy and Aging: A Potential Therapeutic Approach for Age‐Related Oxidative Stress and Cardiac Remodeling. Oxidative Medicine and Cellular Longevity. 2021(1). 8364297–8364297.
10.
Mathieu, Chantal, Stefano Del Prato, Fady T. Botros, et al.. (2018). Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme. Diabetes Obesity and Metabolism. 20(8). 2023–2028.
11.
Paschalis, Eleftherios P., John H. Krege, Sonja Gamsjaeger, et al.. (2018). Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray–Based Bone Assessment Techniques. Journal of Bone and Mineral Research. 33(12). 2230–2235.
12.
Gallwitz, Baptist, Samuel Dagogo‐Jack, Vivian T. Thieu, et al.. (2017). Effect of once‐weekly dulaglutide on glycated haemoglobin ( HbA1c ) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c . Diabetes Obesity and Metabolism. 20(2). 409–418.
13.
Fahrleitner‐Pammer, Astrid, David B. Burr, Harald Dobnig, et al.. (2016). Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment. Bone. 89. 16–24.
14.
Dobnig, Harald, J Štěpán, David B. Burr, et al.. (2009). Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate. Journal of Bone and Mineral Research. 24(12). 1998–2006.
15.
Nemcsik, János, et al.. (2004). Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo. European Journal of Pharmacology. 495(2-3). 179–184.
16.
Pávó, Imre, Éva Morschl, Zoltán Szepes, et al.. (2000). Vasopressin deficiency decreases the frequency of gastroduodenal ulceration in humans. Journal of Physiology-Paris. 94(1). 63–66.
17.
Varga, Csaba, Imre Pávó, Dominique Lamarque, et al.. (1998). Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. European Journal of Pharmacology. 352(2-3). 257–261.
18.
Pávó, Imre, et al.. (1995). Effects of testosterone on the rat renal medullary vasopressin receptor concentration and the antidiuretic response. Life Sciences. 56(14). 1215–1222.
19.
László, Ferenc, G Karácsony, Imre Pávó, Csaba Varga, & I. Rojik. (1994). Aggressive role of vasopressin in development of different gastric lesions in rats. European Journal of Pharmacology. 258(1-2). 15–22.
20.
Pávó, Imre & Falk Fahrenholz. (1990). Differential inactivation of vasopressin receptor subtypes in isolated membranes and intact cells by N‐ethylmaleimide. FEBS Letters. 272(1-2). 205–208.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kristine D. Harper Breakdown of academic impact, for papers by Benjamin Z. Leder Breakdown of academic impact, for papers by R. Bouillon Breakdown of academic impact, for papers by Hunter Heath Breakdown of academic impact, for papers by Aase Handberg Breakdown of academic impact, for papers by Mei Li Breakdown of academic impact, for papers by Dorthe Skovgaard Breakdown of academic impact, for papers by D. Thiébaud Breakdown of academic impact, for papers by Richard Keen Breakdown of academic impact, for papers by Robert W. Downs